{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002384","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me1","EXPERIMENT_ID":"EGAX00001371127","attributes":{"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY":["H3K4me1"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"20 min; 30 sec ON/ 30 sec OFF\""],"CHIP_ANTIBODY_CATALOG":["#BP140"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"EXPERIMENT_TYPE":["Histone H3K4me1"],"CHIP_ANTIBODY_LOT":["A1863-001P"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["0,5 ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["179"],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/82CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"741M","NAME":"S01HFZH1.ERX1345481.H3K4me1.bwa.GRCh38.20160309.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/82CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01HFZH1.ERX1345481.H3K4me1.bwa.GRCh38.20160309.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"bb799bbb0db4840670ff51dea7856d11"},{"FORMAT":"bigBed","SIZE":"1.9M","NAME":"S01HFZH1.ERX1345481.H3K4me1.bwa.GRCh38.broad.20160310.bb","FILE_TYPE":"CHIP_MACS2_BROAD_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/82CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01HFZH1.ERX1345481.H3K4me1.bwa.GRCh38.broad.20160310.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"556eea64757d29266a38c404eab6925f"},{"FORMAT":"BED","SIZE":"2.3M","NAME":"S01HFZH1.ERX1345481.H3K4me1.bwa.GRCh38.broad.20160310.bed.gz","FILE_TYPE":"CHIP_MACS2_BROAD_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/82CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01HFZH1.ERX1345481.H3K4me1.bwa.GRCh38.broad.20160310.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"7e359106418cdb2d139b4f65ffd6fefc"},{"FORMAT":"Text","SIZE":"2.5M","NAME":"S01HFZH1.ERX1345481.H3K4me1.bwa.GRCh38.broad.20160310.xls.gz","FILE_TYPE":"CHIP_MACS2_BROAD_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/82CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01HFZH1.ERX1345481.H3K4me1.bwa.GRCh38.broad.20160310.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"9d240ba59d9b753ac56312a210531b38"}],"dataset_id":"EGAD00001002384","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"82CLL","sample_barcode":"S01HFZH1","attributes":{"DONOR_HEALTH_STATUS":["Chronic Lymphocytic Leukemia"],"DONOR_AGE":["45 - 50"],"MOLECULE":["genomic DNA"],"DISEASE":["Chronic Lymphocytic Leukemia"],"BIOMATERIAL_PROVIDER":["Jose I. Martin-Subero"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["venous blood"],"DISEASE_ONTOLOGY_URI":[{"url":"4","label":"C0023434"}],"SUBJECT_ID":["82CLL"],"SAMPLE_ONTOLOGY_URI":[{"url":"6","label":"UBERON_0013756"}],"GENDER":["female"],"DONOR_ID":["82CLL"],"DONOR_SEX":["Female"]},"SAMPLE_ID":"EGAN00001358558","SAMPLE_DESCRIPTION":"Chronic Lymphocytic Leukemia"}}